Clinical Ink experts discuss a new eCOA model that allows you to use leading technology while maximizing efficiency, cost savings, and control
With increased attention on decentralized clinical trials, a growing number of sponsors and CROs plan to adopt direct data capture (DDC), eCOA, ePRO, and eConsent into their workflows. Several vendors offer all-in-one solutions. But what if you want to build and operationalize studies yourself?
Technology solutions and support services that allow you to build your own study — with your data, your team, your way — may be all you need to execute an electronic source data capture strategy.